NCT05087797View on ClinicalTrials.gov

The Effect of Nicorandil on Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

July 8, 2020

Study Completion Date

July 8, 2020

Conditions
Coronary Artery Disease
Interventions
DRUG

nicorandil

Patients in the nicorandil group were also given nicorandil (Tohoku Nipro Pharmaceutical Corporation, Japan) orally 5 mg three times per day for 3 months

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT05087797 - The Effect of Nicorandil on Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion | Biotech Hunter | Biotech Hunter